However, in other cancers, oHRR biallelic alterations exhibited significantly higher HRD scores than BRCA1/2 biallelic alterations (P<0.001) and oHRR monoallelic alterations (P<0.001), but comparable to wild-type groups (P>0.05). This evidence concerns the gene BRCA1 and cancer.